Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial

BACKGROUND: Secondary hyperparathyroidism is a common complication of chronic kidney disease and is managed using vitamin D replacement therapy. Very few studies have examined the effectiveness of pulse alfacalcidol therapy in comparison to daily oral alfacalcidol therapy in suppressing serum parath...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawalmeh, Osama, Moala, Shaheed, Hamdan, Zakaria, Masri, Huda, Ayoub, Khubaib, Khazneh, Emad, Shraim, Mujahed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774473/
https://www.ncbi.nlm.nih.gov/pubmed/29391823
http://dx.doi.org/10.2147/IJNRD.S149877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774473/
https://www.ncbi.nlm.nih.gov/pubmed/29391823
http://dx.doi.org/10.2147/IJNRD.S149877

Ejemplares similares